LY3079514

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3079514, covering 2018-10-04 to 2018-10-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3079514 in Healthy Participants [Phase 1]